Anthem Biosciences Ltd
|
investors.abl@anthembio.com Website:www.anthembio.com
|
Initial public offering of up to [*] equity shares of face value of Rs. 2 each ("Equity Shares") of Anthem Biosciences Limited ("Company" or "Issuer") for cash at a price of Rs.[*] per equity share (including a share premium of Rs.[*] per equity share) ("Offer Price") aggregating up to Rs. 3395.00 crores (the "Offer") through an offer for sale aggregating up to
Rs. 3395.00 crores comprising up to [*] equity shares of face value of Rs.2 each by Ganesh Sambasivam aggregating up to Rs. 350.00 crores, up to [*] equity shares of face value of
Rs.2 each by K Ravindra Chandrappa, aggregating up to
Rs. 350.00 crores and up to [*] equity shares of face value of Rs.2 each by Viridity Tone llp, aggregating up to
Rs.1325.00 crores and up to [*] equity shares of face value of Rs.2 each by Portsmouth Technologies llc, aggregating up to
Rs. 320.00 crores and up to [*] equity shares of face value of Rs.2 each by Malay J Barua, aggregating up to Rs. 320.00 crores and up to [*] equity shares of face value of Rs.2 each by Rupesh N Kinekar, aggregating up to Rs. 320.00 crores and up to [*] equity shares of face value of Rs.2 each by Satish Sharma, aggregating up to Rs. 320.00 crores and up to [*] equity shares of face value of Rs.2 each by Prakash Kariabettan, aggregating up to Rs.80.00 crores and up to [*] equity shares of face value of Rs.2 each by K Ramakrishnan, aggregating up to Rs. 10.00 crores (collectively, "Selling Shareholders" and such offer for sale of equity shares by the selling shareholders, the "Offer for Sale"). The offer shall constitute [*] % of the post-offer paid up equity share capital of the company.
The offer includes a reservation of up to [*] equity shares of face value of Rs.2 each, aggregating up to Rs. 8.25 crores (constituting up to [*]% of the post-offer paid-up equity share capital) for subscription by eligible employees ("Employee Reservation Portion"). The company, in consultation with the brlms may offer a discount of up to [*] of the offer price to eligible employees bidding in the employee reservation portion ("Employee Discount"), subject to necessary approvals as may be required. The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute [*]% and [*]% of the post-offer paid-up equity share capital of the company, respectively.
Price Band: Rs. 540 to Rs. 570 per equity share of face value of Rs. 10 each.
The floor price is 270 times of the face value and the cap price is 285 times of the face value.
Bids can be made for the minimum of 26 equity shares and in multiples of 26 equity shares thereafter.
A discount of Rs.50 per equity share is being offered to eligible employees bidding in the employee reservation portion.
|
|
|
|
|
Anthem Biosciences Ltd
|
|
Rs Cr |
Lead Managers to the Issue |
0.00 |
Citigroup Global Markets India Pvt Ltd |
Nomura Financial Advisors & Securities (India) P |
|
3395.00 |
|
112.32 |
|
Rs.
540.00
|
|
|
|
|
|
Projects |
Listing of the Equity Shares on the Stock Exchanges
| |
|
|
Ajay Bhardwaj |
Ganesh Sambasivam |
K Ravindra Chandrappa |
|
|
|
|
|
|